3 Digital Services and Life Science Technology Stocks With a Strong Future Roadmap: Datamatics Global Services, Wipro and Indegene

Digital services and life science technology stocks give investors exposure to technology and process services for global enterprises and drug makers. Deal wins, utilisation and client spending decide how much of that demand turns into profit.

This list covers three digital services and life science technology stocks: Datamatics Global Services for digital operations and data analytics, Wipro for IT services and consulting and Indegene for life science commercial and regulatory services. Every figure comes from the latest reported financials and the 9 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Digital Services and Life Science Technology Stocks?

Digital services and life science technology stocks are shares of companies that deliver IT, digital operations and life science services. Results depend on deal wins, utilisation and client spending, so deal wins and margins separate the stronger names.

Digital Services and Life Science Technology Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three digital services and life science technology stocks as of the 9 Oct 2026 close.

Among technology services stocks, Datamatics trades at a premium to the industry P/E, while Wipro and Indegene trade at a discount.

Why Do Digital Services and Life Science Technology Stocks Have a Strong Roadmap in India?

Digital services and life science technology stocks have a strong roadmap in India because companies keep outsourcing technology and operations, and life science firms need specialised digital partners. Three drivers stand out.

• Outsourcing demand: Firms hand technology work to service providers.
• Specialised niches: Life science clients need domain-trained teams.
• Offshore delivery: India-based teams keep costs competitive.

Datamatics Global Services: Digital Operations and Analytics Anchor the Roadmap

Datamatics' roadmap rests on digital operations, data analytics and business process services for global clients, with recurring client contracts supporting revenue.

Revenue grew from Rs 1,227.38 crore in FY22 to Rs 2,043.23 crore in FY26, a 66.5% rise, and FY26 revenue was 15.4% higher than FY25. FY26 net profit was Rs 194.95 crore. In Q1 FY27, revenue grew 10.9% to Rs 532.13 crore, and net profit rose 43.7% to Rs 72.36 crore. Operating margin was 21.15% in FY26 and 23.21% in Q1 FY27 against 18.88% a year earlier.

Debt to equity is 0.14 and return on equity is 15.51%. FY26 operating cash flow was Rs 323.99 crore against capital expenditure of Rs 39.57 crore. Datamatics paid a dividend of Rs 5 per share for FY26, a yield of 0.67%. At a P/E of 20.29 against an industry P/E of 17.30, the stock trades above its industry multiple.

What to watch: Q1 FY27 operating margin was 23.21% against 21.15% for FY26, so margin stability is the figure to follow as volumes grow.

Wipro: Large Client Relationships Build the Next Leg

Wipro's roadmap rests on IT services, consulting and engineering services for global clients, with large client relationships supporting steady revenue.

Revenue grew from Rs 81,373.20 crore in FY22 to Rs 96,497.70 crore in FY26, an 18.6% rise, and FY26 revenue was 3.8% higher than FY25. FY26 net profit was Rs 13,265.50 crore. In Q1 FY27, revenue grew 9.7% to Rs 25,457.60 crore, and net profit rose 0.6% to Rs 3,356.30 crore. Operating margin was 23.44% in FY26.

Debt to equity is 0.23 and return on equity is 14.99%. FY26 operating cash flow was Rs 14,931.60 crore against capital expenditure of Rs 1,560.30 crore. At a P/E of 11.83 against an industry P/E of 17.30, the stock trades below its industry multiple.

What to watch: The P/E of 11.83 against an industry P/E of 17.30 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Indegene: Life Sciences Outsourcing Anchors the Roadmap

Indegene's roadmap rests on commercial, medical and regulatory services for life sciences and pharma companies, with outsourcing by drug makers supporting revenue.

Revenue grew from Rs 1,690.50 crore in FY22 to Rs 3,582.50 crore in FY26, a 111.9% rise, and FY26 revenue was 21.6% higher than FY25. FY26 net profit was Rs 401.10 crore. In Q1 FY27, revenue grew 39.5% to Rs 1,092.10 crore. Operating margin was 19.11% in FY26.

Debt to equity is 0.05 and return on equity is 12.78%. FY26 operating cash flow was Rs 650.80 crore against capital expenditure of Rs 44.30 crore. Indegene paid a dividend of Rs 2.25 per share for FY26, a yield of 0.38%. At a P/E of 35.20 against an industry P/E of 62.79, the stock trades below its industry multiple.

What to watch: The P/E of 35.20 against an industry P/E of 62.79 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Best Digital Services and Life Science Technology Stocks in India: Datamatics vs Wipro vs Indegene on Key Financials

Among the best digital services and life science technology stocks in India, Datamatics leads on return on equity; Wipro leads on FY26 operating margin and the lowest P/E; Indegene leads on FY26 revenue growth and Q1 FY27 revenue growth. The table puts the numbers side by side.

Services company earnings follow deal wins, utilisation and client spending, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Digital Services and Life Science Technology Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen digital services and life science technology stocks and shortlist digital services and life science technology stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check order wins and operating margin across client cycles.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these digital services and life science technology stocks

Risks to Consider Before Investing in Digital Services and Life Science Technology Stocks

• Client spending: Cuts in technology budgets can slow orders.
• Currency: Rupee moves can change reported earnings.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Datamatics, Wipro and Indegene live.

Annual reports and quarterly result presentations are the most reliable places to verify the numbers quoted here, because they show segment details, management commentary and the notes behind each figure.

Comparing a quarter with the same quarter of the previous year gives a cleaner reading than comparing it with the preceding quarter, since seasonal patterns affect many businesses in India.

The shareholding pattern published every quarter shows whether promoters, mutual funds and foreign investors are raising or trimming their holdings, which adds useful context to the financial numbers.

Spreading money across several sectors and company sizes helps keep a portfolio steady, because each business responds differently to interest rates, commodity prices and consumer demand.

Investors who plan to hold for several years often review results twice a year, check whether management delivered on earlier guidance and compare progress with the original reasons for investing.

Final Take: Which Stock Has the Strongest Roadmap?

These three technology services stocks cover IT services, digital operations and life science technology. Datamatics leads on return on equity; Wipro leads on FY26 operating margin and the lowest P/E; Indegene leads on FY26 revenue growth and Q1 FY27 revenue growth.

Across digital services and life science technology stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the digital services and life science technology stocks to buy discussed here.

FAQs on Digital Services and Life Science Technology Stocks

Which are the best digital services and life science technology stocks in India with a strong roadmap?

Ans. Datamatics Global Services, Wipro and Indegene stand out for their roadmaps in IT services, digital operations and life science technology. FY26 revenue growth was 15.4% at Datamatics, 3.8% at Wipro and 21.6% at Indegene, and return on equity ranges from 12.78% to 15.51%.

Is Datamatics Global Services a good stock to buy now?

Ans. Datamatics Global Services has a debt to equity ratio of 0.14, a return on equity of 15.51% and a P/E of 20.29 against an industry P/E of 17.30. Valuation, client spending and currency moves affect results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Datamatics, Wipro and Indegene?

Ans. The P/E ratio is 20.29 for Datamatics (industry 17.30), 11.83 for Wipro (industry 17.30) and 35.20 for Indegene (industry 62.79). Only Datamatics trades at or above the industry multiple.

Which of these digital services and life science technology stocks has the highest return on equity?

Ans. Datamatics Global Services has the highest return on equity at 15.51%, followed by Wipro at 14.99% and Indegene at 12.78%.

What are the risks of investing in digital services and life science technology stocks?

Ans. The main risks are client spending, currency and quarterly trends. Cuts in technology budgets can slow orders.

How did Datamatics, Wipro and Indegene perform in Q1 FY27?

Ans. Datamatics Global Services reported revenue of Rs 532.13 crore, up 10.9% year on year, and net profit rose 43.7% to Rs 72.36 crore. Wipro reported revenue of Rs 25,457.60 crore, up 9.7% year on year, and net profit rose 0.6% to Rs 3,356.30 crore. Indegene reported revenue of Rs 1,092.10 crore, up 39.5% year on year.

Do digital services and life science technology stocks pay dividends?

Ans. Datamatics and Indegene pay dividends. The dividend yield is 0.67% for Datamatics and 0.38% for Indegene, based on dividends declared for FY26.

How can I invest in digital services and life science technology stocks in India?

Ans. You can buy digital services and life science technology stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.